Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment by KATIE THOMAS


The failure to report the issue has not put patients at risk, the F.D.A. said, but the drugmaker could face criminal and civil penalties.

Published: August 6, 2019 at 02:00AM

from NYT Health https://ift.tt/2M3PJn4